The regulation of circRNA and lncRNA protein binding in cardiovascular diseases: Emerging therapeutic targets
Huilei Zhao,Ziqi Tan,Jin Zhou,Yifan Wu,Qingwen Hu,Qing Ling,Jitao Ling,Menglu Liu,Jianyong Ma,Deju Zhang,Yue Wang,Jing Zhang,Peng Yu,Yuan Jiang,Xiao Liu
DOI: https://doi.org/10.1016/j.biopha.2023.115067
2023-07-02
Abstract:Noncoding ribonucleic acids (ncRNAs) are a class of ribonucleic acids (RNAs) that carry cellular information and perform essential functions. This class encompasses various RNAs, such as small nuclear ribonucleic acids (snRNA), small interfering ribonucleic acids (siRNA) and many other kinds of RNA. Of these, circular ribonucleic acids (circRNAs) and long noncoding ribonucleic acids (lncRNAs) are two types of ncRNAs that regulate crucial physiological and pathological processes, including binding, in several organs through interactions with other RNAs or proteins. Recent studies indicate that these RNAs interact with various proteins, including protein 53, nuclear factor-kappa B, vascular endothelial growth factor, and fused in sarcoma/translocated in liposarcoma, to regulate both the histological and electrophysiological aspects of cardiac development as well as cardiovascular pathogenesis, ultimately leading to a variety of genetic heart diseases, coronary heart disease, myocardial infarction, rheumatic heart disease and cardiomyopathies. This paper presents a thorough review of recent studies on circRNA and lncRNAprotein binding within cardiac and vascular cells. It offers insight into the molecular mechanisms involved and emphasizes potential implications for treating cardiovascular diseases.
pharmacology & pharmacy,medicine, research & experimental